Latest news

Filters
March 21, 2005

Debiopharm announces import approval from Elplat® (Oxaliplatin) in Japan

Read more
March 1, 2005

Debiopharm S.A. announces the purchase of all outstanding shares of H3 Pharma

Read more
February 7, 2005

Debiopharm S.A. announces marketing approval for a new formulation of Eloxatin® (Oxaliplatin for injection)

Read more
January 4, 2005

H3 Pharma receives approvable letter from FDA for Sanvar® for esophageal variceal bleeding

Read more
December 20, 2004

Debiopharm S.A. and Rowfarma S. de R.L. de C.V. enter into an Exclusive Licensing Agreement in Mexico for two approved…

Read more
December 17, 2004

Debiopharm S.A. and GPC Biotech AG Announce Partnering of Small Molecule MHC Class II Antagonists Program for Autoimune Diseases

Read more
October 11, 2004

Debiopharm S.A. and Tulane Cancer Center nominate Dr T. Curiel and Dr W. Zou, the 2004 Mauvernay Research Excellences Scholars

Read more
October 6, 2004

New Data presented on Debiopharm´s Debio-025 at the 11th International Symposium on Hepatits C virus and related viruses

Read more
September 29, 2004

Debiopharm and Watson Pharmaceuticals enter into an Exclusive Licensing Agreement for two approved urology products – Trelstar® DEPOT and Trelstar®…

Read more